Related Experiment Video
Updated: Jul 13, 2025
07:32
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.4K
Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities
Sehan Jeong1,2,3, Sharmin Afroz4,3, Donghyun Kang1,2
1Center for RNA Research, Institute for Basic Science, Seoul 08826, Korea.
Molecules and Cells
|October 19, 2023
Summary
Immunotherapy offers new hope for sarcoma patients, despite challenges like low tumor mutation burden. Research explores cancer vaccines, immune checkpoint inhibitors, and cellular therapy for better sarcoma treatment outcomes.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Sarcomas are rare, heterogeneous mesenchymal tumors of bone and soft tissue.
- Current treatments (surgery, chemo, radiation) face challenges with recurrence and metastasis.
- Sarcomas are generally less immunogenic, complicating immunotherapy approaches.
Purpose of the Study:
- To review opportunities and current status of immunotherapy in sarcoma treatment.
- To discuss limitations and potential strategies for overcoming immunotherapy barriers in sarcomas.
- To provide a comprehensive overview of sarcoma immunotherapy for improved patient outcomes.
Main Methods:
- Review of current literature on sarcoma immunotherapy.
- Examination of cancer testis antigens in sarcomas.
- Analysis of progress in cancer vaccines, immune checkpoint inhibitors, and adoptive cellular therapy.
Main Results:
- Sarcomas express cancer testis antigens, presenting potential immunotherapy targets.
- Progress is noted in vaccines, checkpoint inhibitors, and cellular therapies for sarcomas.
- Limitations include low tumor mutation burden and an immunosuppressive tumor microenvironment.
Conclusions:
- Immunotherapy holds promise for sarcomas, but significant challenges remain.
- Strategies to overcome the immunosuppressive tumor microenvironment are crucial.
- Personalized and effective sarcoma immunotherapies require further development.
Related Concept Videos
01:27Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
01:30Cancer Vaccines
383
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
383
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K